0

mixed insulin stage 2 r n 0 r n 0 or ra n 0 ra n 0

management of type 2 diabetes focus on insulin therapy

management of type 2 diabetes focus on insulin therapy

Nội khoa

... R/ N- 0 -R/ N- 0 or RA /N- 0- RA /N- 0 R/ N Serum insulin (mU/L) R/ N 50 Overinsulinization Overinsulinization 40 Overinsulinization 30 SMBG SMBG 20 Reg 10 SMBG SMBG Reg NPH 0 10 12 14 SMBG NPH 16 18 20 22 24 ... Stage RA - RA - RA - G RA RA RA Glargine 50 40 30 RA 20 RA RA 10 Glargine 0 10 12 14 16 18 20 22 24 Hours International Diabetes Center Starting Physiologic Regimen: 0- 0 -0- G Serum insulin (mU/L) ... hours post meal target is reached or 0 .2 U/kg for RA RA RA Glargine 50 40 30 SMBG 20 RA SMBG 10 SMBG RA SMBG Glargine 0 10 12 14 16 18 20 22 24 Hours International Diabetes Center Final Step: RA...
  • 45
  • 507
  • 0
Báo cáo y học:

Báo cáo y học: "Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy" pptx

Báo cáo khoa học

... Cushing’s syndrome due to interaction between inhaled corticosteroids and itraconazole Ann Pharmacother 20 04 , 38:46-9 71 Health Canada Advisory: Important safety information regarding a drug interaction ... president of the Canadian Network for Respiratory Care and co-chief editor of Allergy, Asthma and Clinical Immunology He has received consulting fees and honoraria for continuing education from AstraZeneca, ... 8 :00 am or earlier - No oral glucocorticoids the evening and morning prior to the test - Fasting not required How to Screen? ► If result is normal, screen again in months ► If result is normal but...
  • 12
  • 774
  • 0
báo cáo khoa học:

báo cáo khoa học:" Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the Inhaled Insulin Treatment Questionnaire (IITQ)" pdf

Báo cáo khoa học

... -.18***/-. 10* 04 /. 02 08 / .03 03 / .07 - .03 /- .04 - .04 / .09 * 03 /. 12* * -. 02 / .06 - .05 /03 01 / .05 02 / .03 07 / .08 -.16***/-.16 *** - .06 /- .05 - .00 /- .09 * - .05 /-.11** -.11*/- .09 * - .05 /- .07 - .01 /- .09 * - .05 /-. 12* * - .01 /- .07 ... an unrestricted grant to the authors from MannKind Corporation The authors are responsible for all References Charpentier G, Fleury F, Dubroca I, Vaur L, Clerson P: Electronic pill-boxes in the ... 30 :23 07 -23 08 10 Steiner S, Pfutzner A, Wilson BR, Harzer O, Heinemann L, Rave K: Technosphere Insulin - proof of concept study with a new insulin formulation for pulmonary delivery Exp Clin Endocrinol...
  • 8
  • 309
  • 0
báo cáo khoa học:

báo cáo khoa học:" Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study" pps

Báo cáo khoa học

... improvement of glycaemic control was significantly greater in patients who were switched to insulin therapy or remained on an oral regimen than in patients who remained on insulin therapy Barriers ... of insulin or different forms of insulin applications (e.g inhaled insulin) might be helpful to reduce barriers to insulin therapy and encourage a greater proportion of type diabetic patients ... Barriers towards insulin therapy developed significantly different among the three groups In patients who remained on an oral regimen, the negative appraisal of insulin therapy increased, whereas...
  • 6
  • 325
  • 0
basal insulin therapy in type 2 diabetes

basal insulin therapy in type 2 diabetes

Nội khoa

... in combination with oral therapy A number of insulin treatment regimens have been used in this setting, including neutral protamine Hagedorn (NPH) insulin and ultralente insulin (Ultralente; Eli ... in acTable Key Pharmacodynamic Properties for Different Insulin Preparations6 ,28 Insulin Preparation Lispro Aspart Regular NPH Lente Ultralente Glargine Onset of Action Peak Action (hours) Duration ... and Company]), and long-acting insulins (ultralente insulin and insulin glargine) Short-Acting Insulins Short-acting insulins are used primarily to approximate the normal physiologic responses to...
  • 6
  • 414
  • 1
insulin therapy  practical points

insulin therapy practical points

Nội khoa

... Regimen Blood/Plasma Glucose mg.% Fluid 100 ml/hr Insulin U/ 100 ml Insulin U/ 500 ml KClmeq/ 100 ml < 100 100 - 20 0 20 0- 300 300 - 400 > 400 10% Dextrose 10% Dextrose 10% Dextrose 10% Dextrose N/ Saline 4 10 ... cartridge contain 300 u of insulin Other methods of administration are : a) b) c) d) e) Jet injection Insulin infusion pump Nasal Insulin Infuser Transdermal Insulin Oral Insulin Indications ... their eating habits are often erratic Normally, insulin is stored in vials as hexamers and requires degradation to dimers and monomers for absorption Since in lispro insulin there is interchange...
  • 9
  • 351
  • 1
intensive insulin therapy in critically ill patients

intensive insulin therapy in critically ill patients

Nội khoa

... cerebral trauma, or brain surgery Thoracic surgery, respiratory insufficiency, or both Abdominal surgery or peritonitis Vascular surgery Multiple trauma or severe burns Transplantation Other ... cerebral trauma, or brain surgery Thoracic surgery, respiratory insufficiency, or both Abdominal surgery or peritonitis Vascular surgery Multiple trauma or severe burns Transplantation Other No ... score‡ First 24 hr Median Interquartile range Second 24 hr Median Interquartile range Score >9 in first 24 hr — no (%) TISS -28 score§ First 24 hr Median Interquartile range Second 24 hr Median...
  • 9
  • 372
  • 0
intensive insulin therapy in the medical icu

intensive insulin therapy in the medical icu

Nội khoa

... Survival (%) of 60 Conventional treatment 100 40 80 60 20 Intensive treatment 60 100 Conventional treatment 40 80 60 20 40 40 First 30 days 0 10 20 First 30 days 30 0 10 20 30 0 100 20 0 300 400 ... treatment Conventional treatment 10 20 30 40 50 60 70 80 90 Discharge from ICU 4 .0 3.5 3 .0 2. 5 2. 0 1.5 1 .0 0.5 0. 0 Discharge from Hospital 5 .0 P =0. 0 02 P
  • 13
  • 287
  • 0
short term results of intensive insulin therapy

short term results of intensive insulin therapy

Nội khoa

... 147.54 27 .23 c** 1. 12 0 .26 173 .09 ±31.64 1.17 0. 34b* 1 .21 0 . 20 c** 2. 30 0. 84 a 29 .51±9. 82 23.15±11.83 b 2. 29 0. 88 * 2. 27 0. 55c** b 23 . 10 9.11c** b 22 .11± 10. 87 * a 135 . 20 28 .53 1 30. 61±43. 40 1 20 . 12 21 .26 ... conventional and intensive treatment had normal linear growth Greater weight gain has been reported for patients treated with one of the intensive insulin regimens than for patients treated conventionally ... did not find any difference between the anti -insulin antibody levels before and after intensive treatment Hypertension is one of the most important risk factors for initiation and progression of...
  • 6
  • 314
  • 0
Báo cáo y học:

Báo cáo y học: "Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU" pdf

Báo cáo khoa học

... control and nutrition in the intensive care unit Curr Opin Clin Nutr Metab Care 20 06 , 9: 1 20 - 123 Page of (page number not for citation purposes) 10 11 12 13 14 15 16 Malhotra A: Intensive insulin ... Hoekstra JB: Predisposing factors for hypoglycemia in the intensive care unit Crit Care Med 20 06 , 34:96- 101 Devos P, Ledoux D, Preiser JC: Current practice of glycaemia control in european intensive ... with an increased rate of hypoglycemia: results from a randomized multicentre study (VISEP) [abstract] Infection 20 05 , 33:s 105 Vriesendorp TM, van Santen S, De Vries JH, de Jonge E, Rosendaal FR,...
  • 2
  • 309
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol'''' pptx

Báo cáo khoa học

... days or more were required for benefit to be realized [2] Furthermore, bloodstream infections, acute renal failure requiring renal replacement therapy, red blood cell transfusions and critical ... Implementation of a tight glycaemic control protocol using a web-based insulin dose calculator Anaesthesia 20 05 , 60: 109 3-1 100 Zimmerman CR, Mlynarek ME, Jordan JA, Rajda CA, Horst HM: An insulin infusion ... number not for citation purposes) order of inclusion in study Percentage of time spent in target glycaemic range for each patient, in order of inclusion in study Available online http://ccforum.com/content/11/4 /R7 5...
  • 10
  • 275
  • 0
Báo cáo y học:

Báo cáo y học: " Formulas Pro/con debate: Is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patient" doc

Báo cáo khoa học

... following general surgery, trauma, burns, spinal injuries, cardiothoracic surgery and neurosurgery; is IIT indicated in any or all of these patient groups? Given the bewildering proliferation of ... Nitenberg G, van den Berghe G, Wernerman J; DGEM (German Society for Nutritional Medicine), Ebner C, Hartl W, Heymann C, Spies C; ESPEN (European Society for Parenteral and Enteral Nutrition): ESPEN ... 164 : 20 05 - 20 11 Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ: Insulin therapy protects the central and peripheral nervous system of intensive care patients Neurology 20 05 ,...
  • 6
  • 217
  • 0
intensive insulin therapy

intensive insulin therapy

Nội khoa

... www.diabetesclinic.c 23 Insulin Preparations Rapid-acting Aspart (NovoRapid®) Vial and cartridge Lispro (Humalog®) Start < 15 Short-acting (regular) Start 30- 60 Novolin®ge Toronto Humulin® R Peak hr Vial and ... Penfill® Rapid-acting human insulin analogue (insulin aspart) Novolin®ge Toronto Penfill® Short-acting insulin (insulin injection, human biosynthetic) Novolin®ge NPH Penfill® Intermediate-acting ... Change the dose by increments of 1-4 U • Not more than twice/week • Monitor for PATTERNS in hypoglycemia www.diabetesclinic.c 49 Full Range of Novo Nordisk Insulins 10 12 14 16 18 20 22 24 NovoRapid®...
  • 54
  • 456
  • 0
Báo cáo y học:

Báo cáo y học: "Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes" ppsx

Báo cáo khoa học

... length]a Disutility of age -0. 000 3 Sullivan et al [22 ] Other Parametersd CGM risk reduction for CHD CGM risk reduction for nephropathy 0. 0 50 0 .27 0 0 .01 3 0. 006 0. 107 0. 768 DCCT [ 20 ] DCCT [ 20 ] ... of Colorado Denver, Denver, Aurora, Colorado, USA 3Department of Pharmacy Practice, Regis University, Denver, Colorado, USA Authors’ contributions RBM drafted the manuscript All authors participated ... risk reduction for neuropathy 0. 188 0. 004 0. 593 DCCT [ 20 ] CGM risk reduction for retinopathy 0. 306 0. 075 0. 618 Start age Years since diagnosis Discount rate 40 Selvin et al [21 ] Assumption 20 ...
  • 8
  • 239
  • 0
Báo cáo y học:

Báo cáo y học: " Tight glucose control: should we move from intensive insulin therapy alone to modulation of insulin and nutritional inputs" pps

Báo cáo khoa học

... Critical Care Vol 12 No Kalfon and Preiser results from instructions regarding nutritional intake, allowing insulin infusion rates to be limited to a level lower than usual, or from the intrinsic ... mortality in critically ill patients: systematic review and metaanalysis of randomized controlled trials JPEN J Parenter Enteral Nutr 20 06 , 30: 164-1 72 Vogelzang M, van der Horst IC, Nijsten MW: Hyperglycaemic ... M, Weinreb J, Hoo GW: Intensive insulin therapy in critical care: a review of 12 protocols Diabetes Care 20 07 , 30: 100 5- 101 1 Pittas AG, Siegel RD, Lau J: Insulin therapy and in-hospital mortality...
  • 2
  • 194
  • 0
Báo cáo y học:

Báo cáo y học: "Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study" docx

Báo cáo khoa học

... 6) (0 to 8) 0. 1 percentage of normal median (IQR) 83 (0 to 20 0) 100 (0 to 20 0) 0. 5 133 (0 to 25 0) 100 (0 to 20 0) 0. 09 27 (0 to 163) 1 02 (0 to 197) 0. 1 Voluntary motor unit potential recruitment ... to 2. 60) 0. 9 0. 96 (0. 35 to 2. 63) 0. 9 Other 1. 02 (0. 50 to 20 .7) 0. 9 0. 60 (0 .29 to 1 .26 ) 0 .2 Polytrauma 1 .03 (0. 43 to 2. 49) 0. 9 0. 75 (0 .29 to 1. 90) 0. 5 Respiratory/thoracic 1.43 (0. 75 to 2. 71) 0. 3 ... 0. 74 (0. 50 to 1 .09 ) 0. 1 0. 74 (0. 48 to 1. 12) 0 .2 Number of days treatment with noradrenaline, per day added 1 .0 02 (0. 98 to 1 .03 ) 0. 8 1.16 (1.11 to 1 .22 ) < 0. 000 1 Respiratory/thoracic On admission...
  • 12
  • 248
  • 0

Báo cáo khoa học

... patients The AUCpp has been used only in patients with intermittent parenteral feeding [24 ] Thus, it is not suitable for critically ill patients requiring continuous enteral and /or parenteral ... in man: responses to intravenous glucose infusion Metabolism 1979, Page of (page number not for citation purposes) 19 28 :21 0 -22 0 Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon ... management of severe sepsis and septic shock: 20 08 Intensive Care Med 20 08 , 34:17- 60 Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond...
  • 5
  • 315
  • 0
Báo cáo y học:

Báo cáo y học: "Does intensive insulin therapy really reduce mortality in critically ill surgical patients? A reanalysis of meta-analytic data." pdf

Báo cáo khoa học

... 2/ 5 22 8/ 605 0/ 12 18/51 0/ 15 0. 11 20 . 90 20 90 0 .05 1.37 0. 05 22 .48 24 8/688 0. 50 0.95 2. 79 0. 94 2. 50 0.96 [0. 06, [0. 82, [0. 12, [0. 53, [0. 13, [0. 83, 3.91] 1.11] 11] 62. 48] 1.68] 49 .05 ] 1. 10] 2. 03 ... Paolo) 20 09 , 64:51- 60 Fernandez R, Boque M, Galera A, Rodriquez-Cintron W: Insulin: effect on mortality and renal failure in medical intensive care unit patients [abstract] Proc Am Thor Soc 20 05 , 2: A37 ... of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid...
  • 7
  • 235
  • 0
Một số kiến nghị nhằm hoàn thiện cơ cấu tổ chức, chế độ hoạt động các mô hình công ty mẹ - công ty con và đa mô hình vào áp dụng rộng rãi.doc

Một số kiến nghị nhằm hoàn thiện cơ cấu tổ chức, chế độ hoạt động các mô hình công ty mẹ - công ty con và đa mô hình vào áp dụng rộng rãi.doc

Kế toán

... Số 4 / 20 01 ; Số 9 / 20 02 ; Số 12/ 20 02 Nhà n c Pháp luật Số 12/ 20 02 Tài doanh nghiệp tháng 8 / 20 02 Tạp chí qu n lý Nhà n c Tạp chí Kinh tế - Kế hoạch Số 11 / 20 01 Một số thông tin khác mạng 21 22 ... tỉnh Khánh Hoà Tổng công ty cổ ph n nh n CTM DNNN 100 % v n nhà n c có CTC thuộc loại nhiều loại hình doanh nghiệp 100 % v n nhà n c hoạt động theo Luật Doanh nghiệp nhà n c công ty TNHH thành ... DNNN chậm nhiều nguy n nh n, có hai nguy n nh n li n quan đ n mô hình qu nn i tr n: không mong mu n nhà qu n lý trực tiếp DNNN thờ TCT 90- 91 Một b n bị quy n lợi cổ ph n hoá, b n chẳng đợc gì,...
  • 18
  • 932
  • 1

Xem thêm